The drape has been tested in developing countries overseas and has been found to more accurately measure third stage blood loss when compared with visual methods. The usability of the drape has not yet been evaluated.
The pilot study will involve recruitment of women and health professionals who will use the drape to measure third stage blood loss and then complete a survey about their opinion of the drape’s usability. The data will be used to determine the suitability of using the drape in a clinical trial.
While adherence to monitoring requirements and governance of clinical trials is essential, the system has become complicated for investigator-initiated research using devices. Despite these challenges, the authors of this paper believe that this research programme is justified.
While adherence to monitoring requirements and governance of clinical research is essential, research involving the evaluation of emerging medical technologies can be complicated, particularly for an investigator-initiated (clinician) researcher who does not have the support of a biotech company.
These issues may deter clinician researchers from initiating trials and impede their ability to implement clinical research. Despite the challenges, the effectiveness and safety of technologies must be evaluated for their effectiveness in improving clinical outcomes for patients.
Nurse Researcher. 23, 1, 34-38. doi: 10.7748/nr.23.1.34.e1290
Correspondencesharon.licqurish@unimelb.edu.au
Peer reviewThis article has been subject to double-blind review and checked using antiplagiarism software
Conflict of interestNone declared
Received: 08 November 2013
Accepted: 14 January 2014
or
Alternatively, you can purchase access to this article for the next seven days. Buy now
Are you a student? Our student subscription has content especially for you.
Find out more